![Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet](https://www.thelancet.com/cms/attachment/7191c0c4-9c7b-4fd1-a47a-c0b3d1abfb0d/gr2_lrg.jpg)
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet
![Thomas Dayspring on Twitter: "I hope my graphics help explain that Non-HDL-C (more accurately called apoB-cholesterol) serves as a calculated (free - apart from cost of lipid profile) surrogate estimate of the Thomas Dayspring on Twitter: "I hope my graphics help explain that Non-HDL-C (more accurately called apoB-cholesterol) serves as a calculated (free - apart from cost of lipid profile) surrogate estimate of the](https://pbs.twimg.com/media/FDr014IXsAEU3TZ.jpg:large)
Thomas Dayspring on Twitter: "I hope my graphics help explain that Non-HDL-C (more accurately called apoB-cholesterol) serves as a calculated (free - apart from cost of lipid profile) surrogate estimate of the
![Frontiers | Non-HDL-C Is More Stable Than LDL-C in Assessing the Percent Attainment of Non-fasting Lipid for Coronary Heart Disease Patients Frontiers | Non-HDL-C Is More Stable Than LDL-C in Assessing the Percent Attainment of Non-fasting Lipid for Coronary Heart Disease Patients](https://www.frontiersin.org/files/Articles/649181/fcvm-08-649181-HTML/image_m/fcvm-08-649181-t002.jpg)
Frontiers | Non-HDL-C Is More Stable Than LDL-C in Assessing the Percent Attainment of Non-fasting Lipid for Coronary Heart Disease Patients
![Elevated Serum Non-HDL (High-Density Lipoprotein) Cholesterol and Triglyceride Levels as Residual Risks for Myocardial Infarction Recurrence Under Statin Treatment | Arteriosclerosis, Thrombosis, and Vascular Biology Elevated Serum Non-HDL (High-Density Lipoprotein) Cholesterol and Triglyceride Levels as Residual Risks for Myocardial Infarction Recurrence Under Statin Treatment | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/884d1293-4914-473a-8f58-92b1c70ac7e2/934ga1.jpg)
Elevated Serum Non-HDL (High-Density Lipoprotein) Cholesterol and Triglyceride Levels as Residual Risks for Myocardial Infarction Recurrence Under Statin Treatment | Arteriosclerosis, Thrombosis, and Vascular Biology
![Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients | Journal of the American College of Cardiology Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/779941fe-a063-4965-91eb-9f7beb4b7c8a/gr5.jpg)
Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients | Journal of the American College of Cardiology
![PDF] Non-HDL cholesterol is better than LDL-c at predicting atherosclerotic cardiovascular disease risk factors clustering, even in subjects with near-to-normal triglycerides: A report | Semantic Scholar PDF] Non-HDL cholesterol is better than LDL-c at predicting atherosclerotic cardiovascular disease risk factors clustering, even in subjects with near-to-normal triglycerides: A report | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/77450645cc767152694e6947b38b931e1522667f/5-Table1-1.png)
PDF] Non-HDL cholesterol is better than LDL-c at predicting atherosclerotic cardiovascular disease risk factors clustering, even in subjects with near-to-normal triglycerides: A report | Semantic Scholar
![Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet](https://www.thelancet.com/cms/attachment/0c37580c-c143-4f36-88f9-6b0d46ba0da9/gr1_lrg.jpg)
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium - The Lancet
![Triglyceride/low-density-lipoprotein cholesterol ratio is the most valuable predictor for increased small, dense LDL in type 2 diabetes patients | Lipids in Health and Disease | Full Text Triglyceride/low-density-lipoprotein cholesterol ratio is the most valuable predictor for increased small, dense LDL in type 2 diabetes patients | Lipids in Health and Disease | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12944-021-01612-8/MediaObjects/12944_2021_1612_Fig3_HTML.png)
Triglyceride/low-density-lipoprotein cholesterol ratio is the most valuable predictor for increased small, dense LDL in type 2 diabetes patients | Lipids in Health and Disease | Full Text
Association between Non-High-Density-Lipoprotein-Cholesterol Levels and the Prevalence of Asymptomatic Intracranial Arterial Stenosis | PLOS ONE
![The importance of maintaining normal cholesterol levels, even at a young age - Observatoire de la prévention The importance of maintaining normal cholesterol levels, even at a young age - Observatoire de la prévention](https://observatoireprevention.org/wp-content/uploads/2020/01/Threshold_to_start_treatment-scaled.jpg)